Cboe Global Markets, Inc. (CBOE)
BATS: CBOE · Real-Time Price · USD
353.27
+0.20 (0.06%)
Nov 6, 2026, 4:00 PM EST - Market closed

Cboe Global Markets Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Revenue
1,3591,4431,2731,2041,1421,1741,1951,1081,056974957.2968.7908.8907.8988.21,005993.5985.8974.5866.4
1,3591,4431,2731,2041,1421,1741,1951,1081,056974957.2968.7908.8907.8988.21,005993.5985.8974.5866.4
Revenue Growth (YoY)
19.02%22.95%6.51%8.70%8.15%20.48%24.84%14.34%16.16%7.29%-3.14%-3.58%-8.53%-7.91%1.41%15.96%21.63%23.10%-3.59%2.63%
Cost of Revenue
646.6711.2543.9532.9536.2586.2629.8583.1523.7460.2455.1469.7428.3440.7516.8547.6551.1561.7556.4475.9
Gross Profit
712.2731.6728.9671.1605.5587.3565.2524.5532513.8502.1499480.5467.1471.4457.1442.4424.1418.1390.5
Selling, General & Admin
184.8198.3188197193.3194.4175.2186.4185181.9175175160.6174.9170.3154.7153.8140.5129.5122.4
Other Operating Expenses
20.25.55.873.86.65.65.38.75.46.86.99.16.95.410.48.46.464.5
Operating Expenses
232.7231.9223.3235.3228230.9211.1223.8225.5219.1219.1219.9208.5221.6217.1209.8203.2187.1176.4168.9
Operating Income
479.5499.7505.6435.8377.5356.4354.1300.7306.5294.7283279.1272245.5254.3247.3239.2237241.7221.6
Interest Expense
-13.1-13.2-13.3-13.3-13.3-12.9-12.8-12.9-12.8-12.8-13-13.2-15.4-16.7-17.1-17.1-16.1-15.1-11.7-11.5
Interest & Investment Income
24.33117.759.96711.38.4712.418.818.110.413.814.217.38.60.80.50.90.4
Earnings From Equity Investments
----------------4.7---3.1-
Other Non Operating Income (Expenses)
90.96.2-3.86.1-1.840.53.22.94.6-1.90.5-0.50.12.97.5-3-0.90.7
EBT Excluding Unusual Items
499.7518.4516.2478.6437.3353353.7295.3309.3303.6292.7274.4270.9242.5254.6237231.4219.4226.9211.2
Merger & Restructuring Charges
-16.7-23.7--6.9-7.2-0.2-0.2-2.2--0.6-0.60.5-0.8-0.7-6.4-2-1.6-14.3-2-3.7
Impairment of Goodwill
-----------------0.8-460.1--
Gain (Loss) on Sale of Investments
---0.75.1--1.1-3.3-14.4-1.2-16--1.8----4.4--3.1--
Gain (Loss) on Sale of Assets
71.5------1------------
Asset Writedown
----25.1--17.1----81----------
Other Unusual Items
--------0.9-3-14.4---5.2-1.3-2.7
Pretax Income
554.5494.7515.5451.7430.1334.6350.2279.7309203292.1287.5270.1241.8248.2235.8229-256.8224.9210.2
Income Tax Expense
126.3141.6129.8138.2129.399.599.683.290.562.682.675.561.97474.876.178.8-72.3115.344.3
Earnings From Continuing Operations
428.2353.1385.7313.5300.8235.1250.6196.5218.5140.4209.5212208.2167.8173.4159.7150.2-184.5109.6165.9
Net Income
428.2353.1385.7313.5300.8235.1250.6196.5218.5140.4209.5212208.2167.8173.4159.7150.2-184.5109.6165.9
Preferred Dividends & Other Adjustments
1.51.31.61.31.51.21.20.91.10.71.21.21.10.80.80.30.6-0.40.6
Net Income to Common
426.7351.8384.1312.2299.3233.9249.4195.6217.4139.7208.3210.8207.1167172.6159.4149.6-184.5109.2165.3
Net Income Growth (YoY)
42.57%50.41%54.01%59.61%37.67%67.43%19.73%-7.21%4.97%-16.35%20.68%32.25%38.44%-58.06%-3.57%24.67%--20.18%89.78%
Shares Outstanding (Basic)
105105105105105105105105105105106106106106106106106106107107
Shares Outstanding (Diluted)
105105105105105105105105105105106106106106106107106106107107
Shares Change (YoY)
-0.19%-0.10%-0.10%-0.10%-0.19%-0.38%-0.94%-1.04%-0.94%-0.66%-0.09%-0.28%-0.28%-0.19%-0.56%-0.56%-0.56%-0.56%-0.56%-0.83%
EPS (Basic)
4.083.363.672.982.862.232.381.872.081.331.971.991.961.581.631.501.41-1.741.021.55
EPS (Diluted)
4.083.353.662.972.852.232.371.852.071.331.961.981.951.571.631.491.41-1.741.021.54
EPS Growth (YoY)
43.16%50.22%54.43%60.52%37.68%67.77%20.92%-6.47%6.15%-15.34%20.26%32.58%38.43%-59.79%-3.11%25.77%--19.68%91.79%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
793-536.31,941332.1137.9313.4898.2-734.2-590.51,476888.3-206.1729.2-510.91,018-171159.1-645.81,249-702.3
Free Cash Flow Per Share
7.57-5.1118.483.161.312.988.55-6.99-5.6214.018.37-1.946.87-4.829.59-1.611.50-6.0811.70-6.56
Dividend Per Share
0.8600.7200.7200.7200.7200.6300.6300.6300.6300.5500.5500.5500.5500.5000.5000.5000.5000.4800.4800.480
Dividend Growth (YoY)
19.44%14.29%14.29%14.29%14.29%14.54%14.54%14.54%14.54%10.00%10.00%10.00%10.00%4.17%4.17%4.17%4.17%14.29%14.29%14.29%
Gross Margin
52.41%50.71%57.27%55.74%53.03%50.05%47.30%47.36%50.39%52.75%52.45%51.51%52.87%51.45%47.70%45.50%44.53%43.02%42.90%45.07%
Operating Margin
35.29%34.63%39.72%36.20%33.06%30.37%29.63%27.15%29.03%30.26%29.57%28.81%29.93%27.04%25.73%24.61%24.08%24.04%24.80%25.58%
Profit Margin
31.40%24.38%30.18%25.93%26.21%19.93%20.87%17.66%20.59%14.34%21.76%21.76%22.79%18.40%17.47%15.87%15.06%-18.72%11.21%19.08%
Free Cash Flow Margin
58.36%-37.17%152.48%27.58%12.08%26.71%75.16%-66.29%-55.93%151.55%92.80%-21.28%80.24%-56.28%103.06%-17.02%16.01%-65.51%128.17%-81.06%
EBITDA
505525.5532.8464.2406.1383.8381.9330335.8324317.8314.9308.7283.2293.7290.1278.4275.4280.9261.6
EBITDA Margin
37.16%36.42%41.86%38.55%35.57%32.71%31.96%29.79%31.81%33.27%33.20%32.51%33.97%31.20%29.72%28.87%28.02%27.94%28.82%30.19%
D&A For EBITDA
25.525.827.228.428.627.427.829.329.329.334.835.836.737.739.442.839.238.439.240
EBIT
479.5499.7505.6435.8377.5356.4354.1300.7306.5294.7283279.1272245.5254.3247.3239.2237241.7221.6
EBIT Margin
35.29%34.63%39.72%36.20%33.06%30.37%29.63%27.15%29.03%30.26%29.57%28.81%29.93%27.04%25.73%24.61%24.08%24.04%24.80%25.58%
Effective Tax Rate
22.78%28.62%25.18%30.60%30.06%29.74%28.44%29.75%29.29%30.84%28.28%26.26%22.92%30.60%30.14%32.27%34.41%-51.27%21.07%
Revenue as Reported
1,3591,4431,2731,2041,1421,1741,1951,1081,056974957.2968.7908.8907.8988.21,005993.5985.8974.5866.4
SEC Filings: 10-K · 10-Q